dc.contributor.author | Huntington, Jane | eng |
dc.contributor.author | Zantop, Veronika | eng |
dc.date.issued | 2004 | eng |
dc.description.abstract | Selective serotonin reuptake inhibitors (SSRIs) are considered first-line agents for the treatment of depression in pregnant women. SSRIs and tricyclic antidepressants (TCAs) are considered safe and effective in pregnant women, although some studies have indicated increased short-term neonatal adverse effects after exposure to antidepressants in the third trimester.[Strength of recommendation: B, based on cohort studies.] | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3930 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2004 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | American family physician, 70, no. 11 (December 2004) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | neonatal toxicity | eng |
dc.subject | antidepressant therapy | eng |
dc.subject | neonatal withdrawal syndrome | eng |
dc.subject.lcsh | Antidepressants | eng |
dc.subject.lcsh | Obstetrical pharmacology | eng |
dc.subject.lcsh | Fetus -- Effect of drugs on | eng |
dc.subject.lcsh | Newborn infants -- Effect of drugs on | eng |
dc.subject.lcsh | Pregnant women -- Drug use | eng |
dc.subject.mesh | Maternal-Fetal Exchange -- drug effects | eng |
dc.title | Antidepressant Medications in Pregnancy | eng |
dc.type | Article | eng |